Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | STK17B | O94768 | 1/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.33 |
| ▸ | PRKCA | P17252 | 4/20 | 0.31 |
| ▸ | CNR2 | P34972 | 4/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6824412 | 0.89 | MAOA (0.35) | MTNR1AMAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6820565 | 0.86 | KCNA3 (0.36) | MTNR1AMAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6823667 | 0.81 | KCNA3 (0.37) | MTNR1AMAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6824996 | 0.80 | STK17B (0.36) | MTNR1AMAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6426238 | 0.75 | KCNA3 (0.37) | MTNR1AMAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6823698 | 0.74 | TYR (0.43) | MAOAMAOBHSP90AA1ALDH1A1HPGD | |
| SCHEMBL6820563 | 0.74 | KCNA3 (0.39) | MTNR1AMAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6422310 | 0.73 | MTNR1A (0.36) | MTNR1AMAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6826162 | 0.73 | STK17B (0.37) | MAOAMAOBSTK17BKCNA3 | |
| SCHEMBL6823716 | 0.72 | KCNA3 (0.38) | MTNR1AMAOAMAOBSTK17BKCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004076444-A2 | NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-10 | — | — | WO | disclosed |